SMARCA4 and lung carcinoma: Genomic analysis of SMARCA4 mutations in lung cancer demonstrates that SMARCA4 mutations, primarily located in the SNF2‐related and helicase conserved C‐terminal domains, are associated with a poorer prognosis in lung cancer.